Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO5986 | Ziziphus jujuba | Species | Rhamnaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2560 | Protein Family | Phosphodiesterase 4 | Homo sapiens | IC50 | = | 59000 | nM | 6245211 |
NPT2560 | Protein Family | Phosphodiesterase 4 | Homo sapiens | IC50 | = | 22000 | nM | 6245211 |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 10864.26 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 12647.36 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 16519.62 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 16405.9 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 5046.61 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 3605.79 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 12189.9 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 48977.88 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 12502.59 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 152054.75 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 152405.28 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 2824.88 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 67608.3 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 44874.54 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 19498.45 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 6998.42 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 67764.15 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 6668.07 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 5420.01 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 27669.42 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 122461.62 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 3147.75 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 4698.94 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 21527.82 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 12078.14 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 15135.61 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 299916.25 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 27101.92 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 8016.78 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 75509.22 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 18071.74 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 6471.43 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 51999.6 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 16595.87 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 5688.53 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 2697.74 | nM | PubChem BioAssay data set | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 36728.23 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 99770.01 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 13489.63 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 22750.97 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 31768.74 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 37757.22 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 6698.85 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 3006.08 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 31988.95 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 8109.61 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 35563.13 | nM | PubChem BioAssay data set | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 26730.06 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 8298.51 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 14655.48 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 10616.96 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 7030.72 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 15667.51 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 5407.54 | nM | PubChem BioAssay data set | |
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 4528.98 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 3605.79 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 24547.09 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 51168.18 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 28707.81 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 164816.24 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 8851.16 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 42559.84 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 3810.66 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 3483.37 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 6180.16 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 295120.92 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 8394.6 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 7345.14 | nM | PubChem BioAssay data set | |
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 7261.06 | nM | PubChem BioAssay data set | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 108893.01 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC224076 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9859 | High Similarity | NPC302778 |
0.9859 | High Similarity | NPC212551 |
0.9718 | High Similarity | NPC185991 |
0.9718 | High Similarity | NPC211025 |
0.9718 | High Similarity | NPC85689 |
0.965 | High Similarity | NPC321814 |
0.9583 | High Similarity | NPC130586 |
0.9583 | High Similarity | NPC164952 |
0.9517 | High Similarity | NPC174802 |
0.9507 | High Similarity | NPC121222 |
0.9437 | High Similarity | NPC269827 |
0.9388 | High Similarity | NPC316618 |
0.9388 | High Similarity | NPC226245 |
0.931 | High Similarity | NPC161224 |
0.9296 | High Similarity | NPC156461 |
0.9296 | High Similarity | NPC21448 |
0.9296 | High Similarity | NPC107374 |
0.9231 | High Similarity | NPC189068 |
0.9231 | High Similarity | NPC164665 |
0.9167 | High Similarity | NPC309832 |
0.9167 | High Similarity | NPC219313 |
0.9155 | High Similarity | NPC229974 |
0.9155 | High Similarity | NPC314152 |
0.9079 | High Similarity | NPC323091 |
0.9014 | High Similarity | NPC209525 |
0.9014 | High Similarity | NPC161659 |
0.8881 | High Similarity | NPC317821 |
0.8861 | High Similarity | NPC326529 |
0.8859 | High Similarity | NPC472816 |
0.8805 | High Similarity | NPC319100 |
0.8805 | High Similarity | NPC324198 |
0.8726 | High Similarity | NPC326082 |
0.8718 | High Similarity | NPC261595 |
0.8662 | High Similarity | NPC324033 |
0.8662 | High Similarity | NPC321458 |
0.8627 | High Similarity | NPC239737 |
0.8609 | High Similarity | NPC207633 |
0.8571 | High Similarity | NPC189261 |
0.8552 | High Similarity | NPC129756 |
0.8477 | Intermediate Similarity | NPC150853 |
0.8411 | Intermediate Similarity | NPC136349 |
0.8387 | Intermediate Similarity | NPC311197 |
0.8387 | Intermediate Similarity | NPC54320 |
0.8387 | Intermediate Similarity | NPC313754 |
0.8323 | Intermediate Similarity | NPC52238 |
0.8267 | Intermediate Similarity | NPC89147 |
0.8267 | Intermediate Similarity | NPC274384 |
0.8247 | Intermediate Similarity | NPC328479 |
0.8231 | Intermediate Similarity | NPC33996 |
0.8231 | Intermediate Similarity | NPC30326 |
0.8219 | Intermediate Similarity | NPC320818 |
0.8079 | Intermediate Similarity | NPC251233 |
0.8079 | Intermediate Similarity | NPC211820 |
0.8067 | Intermediate Similarity | NPC186619 |
0.8026 | Intermediate Similarity | NPC177169 |
0.7987 | Intermediate Similarity | NPC195140 |
0.7974 | Intermediate Similarity | NPC64705 |
0.7974 | Intermediate Similarity | NPC232408 |
0.7961 | Intermediate Similarity | NPC318590 |
0.7925 | Intermediate Similarity | NPC93365 |
0.7908 | Intermediate Similarity | NPC317746 |
0.7885 | Intermediate Similarity | NPC326694 |
0.7853 | Intermediate Similarity | NPC324484 |
0.7818 | Intermediate Similarity | NPC290959 |
0.7805 | Intermediate Similarity | NPC325906 |
0.7738 | Intermediate Similarity | NPC313897 |
0.7733 | Intermediate Similarity | NPC61198 |
0.7667 | Intermediate Similarity | NPC262926 |
0.7622 | Intermediate Similarity | NPC14590 |
0.7562 | Intermediate Similarity | NPC321052 |
0.7529 | Intermediate Similarity | NPC24589 |
0.75 | Intermediate Similarity | NPC282458 |
0.75 | Intermediate Similarity | NPC78941 |
0.7483 | Intermediate Similarity | NPC319221 |
0.7417 | Intermediate Similarity | NPC324009 |
0.7303 | Intermediate Similarity | NPC313514 |
0.7215 | Intermediate Similarity | NPC315642 |
0.7215 | Intermediate Similarity | NPC74306 |
0.7076 | Intermediate Similarity | NPC33382 |
0.7035 | Intermediate Similarity | NPC168702 |
0.7035 | Intermediate Similarity | NPC125659 |
0.7021 | Intermediate Similarity | NPC276373 |
0.6984 | Remote Similarity | NPC5802 |
0.6954 | Remote Similarity | NPC222174 |
0.6947 | Remote Similarity | NPC157821 |
0.6897 | Remote Similarity | NPC107160 |
0.6842 | Remote Similarity | NPC321393 |
0.6796 | Remote Similarity | NPC21461 |
0.6733 | Remote Similarity | NPC327579 |
0.6619 | Remote Similarity | NPC158055 |
0.6552 | Remote Similarity | NPC250178 |
0.6541 | Remote Similarity | NPC57279 |
0.6528 | Remote Similarity | NPC476564 |
0.6519 | Remote Similarity | NPC246193 |
0.6519 | Remote Similarity | NPC104011 |
0.6434 | Remote Similarity | NPC174114 |
0.6434 | Remote Similarity | NPC87981 |
0.641 | Remote Similarity | NPC248007 |
0.6309 | Remote Similarity | NPC4837 |
0.6309 | Remote Similarity | NPC312187 |
0.6263 | Remote Similarity | NPC103388 |
0.6244 | Remote Similarity | NPC160666 |
0.6218 | Remote Similarity | NPC139776 |
0.6211 | Remote Similarity | NPC287876 |
0.6171 | Remote Similarity | NPC472834 |
0.6149 | Remote Similarity | NPC14330 |
0.6081 | Remote Similarity | NPC18335 |
0.5938 | Remote Similarity | NPC109322 |
0.5904 | Remote Similarity | NPC164845 |
0.5872 | Remote Similarity | NPC217656 |
0.586 | Remote Similarity | NPC68938 |
0.5838 | Remote Similarity | NPC89139 |
0.5824 | Remote Similarity | NPC296437 |
0.5789 | Remote Similarity | NPC470266 |
0.5776 | Remote Similarity | NPC5707 |
0.5769 | Remote Similarity | NPC313547 |
0.5739 | Remote Similarity | NPC244700 |
0.5723 | Remote Similarity | NPC476528 |
0.5723 | Remote Similarity | NPC476433 |
0.5706 | Remote Similarity | NPC180493 |
0.5692 | Remote Similarity | NPC265111 |
0.5691 | Remote Similarity | NPC472833 |
0.569 | Remote Similarity | NPC476013 |
0.569 | Remote Similarity | NPC476522 |
0.569 | Remote Similarity | NPC476520 |
0.569 | Remote Similarity | NPC474986 |
0.5682 | Remote Similarity | NPC476408 |
0.566 | Remote Similarity | NPC189314 |
0.5657 | Remote Similarity | NPC476521 |
0.5648 | Remote Similarity | NPC473585 |
0.5629 | Remote Similarity | NPC476561 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC224076 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD169 | Phase 2 |
0.9718 | High Similarity | NPD283 | Approved |
0.9583 | High Similarity | NPD242 | Approved |
0.9583 | High Similarity | NPD338 | Approved |
0.9517 | High Similarity | NPD339 | Approved |
0.9437 | High Similarity | NPD186 | Discovery |
0.9296 | High Similarity | NPD250 | Approved |
0.9296 | High Similarity | NPD249 | Approved |
0.9167 | High Similarity | NPD195 | Approved |
0.9155 | High Similarity | NPD185 | Approved |
0.9028 | High Similarity | NPD166 | Approved |
0.8839 | High Similarity | NPD7988 | Suspended |
0.8805 | High Similarity | NPD4171 | Clinical (unspecified phase) |
0.88 | High Similarity | NPD1369 | Phase 2 |
0.88 | High Similarity | NPD3107 | Discontinued |
0.88 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.875 | High Similarity | NPD193 | Suspended |
0.875 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.875 | High Similarity | NPD2646 | Discontinued |
0.8718 | High Similarity | NPD247 | Clinical (unspecified phase) |
0.8645 | High Similarity | NPD3083 | Approved |
0.8627 | High Similarity | NPD1732 | Phase 3 |
0.8627 | High Similarity | NPD2624 | Phase 2 |
0.8528 | High Similarity | NPD4716 | Approved |
0.8476 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.8411 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.8387 | Intermediate Similarity | NPD218 | Approved |
0.8387 | Intermediate Similarity | NPD217 | Approved |
0.8387 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.8387 | Intermediate Similarity | NPD216 | Approved |
0.8387 | Intermediate Similarity | NPD219 | Phase 3 |
0.8313 | Intermediate Similarity | NPD2647 | Phase 3 |
0.8284 | Intermediate Similarity | NPD2632 | Approved |
0.8284 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8284 | Intermediate Similarity | NPD2630 | Approved |
0.8194 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD214 | Approved |
0.8171 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8166 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD248 | Discontinued |
0.7931 | Intermediate Similarity | NPD9633 | Phase 3 |
0.7925 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.7908 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7877 | Intermediate Similarity | NPD9632 | Phase 3 |
0.7847 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7805 | Intermediate Similarity | NPD1776 | Approved |
0.7805 | Intermediate Similarity | NPD1777 | Approved |
0.7771 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7764 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.774 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7644 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7644 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7644 | Intermediate Similarity | NPD5682 | Phase 3 |
0.763 | Intermediate Similarity | NPD1692 | Approved |
0.7561 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD549 | Approved |
0.7514 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7434 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD3695 | Approved |
0.7419 | Intermediate Similarity | NPD3696 | Approved |
0.7346 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD7138 | Phase 2 |
0.7247 | Intermediate Similarity | NPD1063 | Phase 2 |
0.7215 | Intermediate Similarity | NPD582 | Approved |
0.7125 | Intermediate Similarity | NPD171 | Discontinued |
0.7117 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7073 | Intermediate Similarity | NPD353 | Discontinued |
0.7068 | Intermediate Similarity | NPD2824 | Phase 2 |
0.7063 | Intermediate Similarity | NPD4240 | Approved |
0.7 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD2876 | Phase 3 |
0.6928 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD2902 | Phase 2 |
0.691 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6869 | Remote Similarity | NPD5080 | Phase 2 |
0.6826 | Remote Similarity | NPD9605 | Phase 3 |
0.6818 | Remote Similarity | NPD5079 | Phase 2 |
0.6779 | Remote Similarity | NPD9606 | Approved |
0.6733 | Remote Similarity | NPD9607 | Approved |
0.665 | Remote Similarity | NPD4495 | Phase 1 |
0.6619 | Remote Similarity | NPD6840 | Approved |
0.6604 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6579 | Remote Similarity | NPD9409 | Discontinued |
0.6541 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6477 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6467 | Remote Similarity | NPD1730 | Discontinued |
0.6467 | Remote Similarity | NPD9374 | Approved |
0.6443 | Remote Similarity | NPD9373 | Approved |
0.6438 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.641 | Remote Similarity | NPD9084 | Phase 2 |
0.6405 | Remote Similarity | NPD307 | Approved |
0.6375 | Remote Similarity | NPD282 | Approved |
0.6358 | Remote Similarity | NPD1119 | Phase 2 |
0.6294 | Remote Similarity | NPD775 | Approved |
0.6263 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6244 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6244 | Remote Similarity | NPD4458 | Phase 2 |
0.6228 | Remote Similarity | NPD1431 | Approved |
0.6228 | Remote Similarity | NPD2253 | Discontinued |
0.6228 | Remote Similarity | NPD1430 | Approved |
0.6211 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6196 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6196 | Remote Similarity | NPD1058 | Discontinued |
0.6182 | Remote Similarity | NPD6112 | Approved |
0.6178 | Remote Similarity | NPD207 | Discontinued |
0.6144 | Remote Similarity | NPD9584 | Phase 2 |
0.614 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6089 | Remote Similarity | NPD2452 | Phase 2 |
0.6089 | Remote Similarity | NPD2453 | Phase 2 |
0.6089 | Remote Similarity | NPD2451 | Phase 2 |
0.6089 | Remote Similarity | NPD2450 | Phase 2 |
0.6087 | Remote Similarity | NPD1128 | Approved |
0.6087 | Remote Similarity | NPD1127 | Approved |
0.6081 | Remote Similarity | NPD8836 | Approved |
0.6062 | Remote Similarity | NPD281 | Approved |
0.6061 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6056 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6048 | Remote Similarity | NPD799 | Phase 1 |
0.6048 | Remote Similarity | NPD1808 | Phase 1 |
0.6019 | Remote Similarity | NPD6381 | Phase 2 |
0.5976 | Remote Similarity | NPD1118 | Discontinued |
0.597 | Remote Similarity | NPD5486 | Discontinued |
0.596 | Remote Similarity | NPD9416 | Phase 3 |
0.596 | Remote Similarity | NPD9417 | Phase 3 |
0.596 | Remote Similarity | NPD691 | Discontinued |
0.5956 | Remote Similarity | NPD8250 | Phase 2 |
0.5948 | Remote Similarity | NPD9375 | Discontinued |
0.5941 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5941 | Remote Similarity | NPD34 | Approved |
0.5941 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.5941 | Remote Similarity | NPD4714 | Approved |
0.5938 | Remote Similarity | NPD798 | Discontinued |
0.5936 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5928 | Remote Similarity | NPD1120 | Approved |
0.5928 | Remote Similarity | NPD1121 | Approved |
0.5928 | Remote Similarity | NPD535 | Approved |
0.5882 | Remote Similarity | NPD5458 | Discontinued |
0.5867 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.5828 | Remote Similarity | NPD515 | Phase 1 |
0.5814 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5806 | Remote Similarity | NPD9582 | Phase 3 |
0.5789 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5785 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5776 | Remote Similarity | NPD8830 | Phase 3 |
0.5767 | Remote Similarity | NPD6036 | Suspended |
0.5732 | Remote Similarity | NPD9406 | Approved |
0.573 | Remote Similarity | NPD7842 | Phase 2 |
0.5723 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5706 | Remote Similarity | NPD78 | Approved |
0.5706 | Remote Similarity | NPD9544 | Approved |
0.5701 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5701 | Remote Similarity | NPD5627 | Approved |
0.57 | Remote Similarity | NPD796 | Phase 2 |
0.5691 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5665 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.566 | Remote Similarity | NPD8831 | Approved |
0.566 | Remote Similarity | NPD8833 | Approved |
0.5652 | Remote Similarity | NPD6351 | Discovery |
0.5633 | Remote Similarity | NPD757 | Phase 3 |
0.5628 | Remote Similarity | NPD537 | Phase 2 |
0.5628 | Remote Similarity | NPD534 | Phase 2 |
0.5625 | Remote Similarity | NPD9360 | Approved |
PubChem CID   | 100299 |
ChEMBL   | CHEMBL2107085 |
ZINC   |
Molecular Weight:   | 363.01 |
ALogP:   | -1.3063 |
MLogP:   | 1.13 |
XLogP:   | -2.362 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 164.65 |
# H-Bond Aceptor:   | 11 |
# H-Bond Donor:   | 3 |
# Rings:   | 4 |
# Heavy Atoms:   | 23 |